Mumbai: Pharma major Zydus Cadila on Monday reported a growth of 39 percent in its consolidated net profit for the first quarter ended June 30 to Rs 124.79 crore, over the same period a year earlier.
Consolidated total income of the company also rose to Rs 907.76 crore during the April-June period of this fiscal from Rs 715.62 crore of the same period last year, Cadila Healthcare (Zydus Cadila) said in a filing to the Bombay Stock Exchange (BSE).
On a standalone basis, the drug maker posted a net profit of Rs 122.56 crore in the latest quarter of FY'10, whereas the same was at Rs 55.64 crore in the corresponding period a year ago.
"The standalone figures for the current quarter are not comparable with the figures of the corresponding quarter of the previous year because of demerger of consumer products division, which got merged with Zydus Wellness, a subsidiary of Cadila Healthcare," the filing said.
Shares of Cadila Healthcare were trading at Rs 399.05, up 2.54 percent in afternoon trade on the BSE.
Bureau Report
First Published: Monday, July 27, 2009, 16:25